CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Activity

203 hedge funds and large institutions have $3.76B invested in Crinetics Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 78 increasing their positions, 55 reducing their positions, and 28 closing their positions.

Holders
203
Holders Change
+22
Holders Change %
+12.15%
% of All Funds
2.94%
Holding in Top 10
13
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+44.44%
% of All Funds
0.19%
New
50
Increased
78
Reduced
55
Closed
28
Calls
$34.1M
Puts
$28.1M
Net Calls
+$6.03M
Net Calls Change
-$4.54M

Top Buyers

1
EC
1
EcoR1 Capital
California
$195M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$232M
3
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$92.5M
4
AG
4
Artal Group
Luxembourg
$65.1M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$179M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$28.7M
2
APM
2
Avidity Partners Management
Texas
$0
3
VPC
3
Vestal Point Capital
New York
$0
4
State Street
4
State Street
Massachusetts
$152M
5
FLSM
5
Frazier Life Sciences Management
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$254M 5,436,104 +90,990 +2%
DCM
2
Driehaus Capital Management
Illinois
$245M 5,226,297 +186,340 +4%
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$232M 4,949,486 +1,532,586 +45%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$209M 4,463,676 +419,811 +10%
EC
5
EcoR1 Capital
California
$195M 4,155,375 +2,142,858 +106%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$179M 3,823,218 +814,360 +27%
Vanguard Group
7
Vanguard Group
Pennsylvania
$167M 3,575,076 +72,624 +2%
State Street
8
State Street
Massachusetts
$152M 3,255,253 -308,483 -9%
PBA
9
Paradigm Biocapital Advisors
New York
$146M 3,124,749 +811,830 +35%
Wellington Management Group
10
Wellington Management Group
Massachusetts
$139M 2,971,582 -273,523 -8%
Jennison Associates
11
Jennison Associates
New York
$132M 2,817,854 +270,171 +11%
T. Rowe Price Investment Management
12
T. Rowe Price Investment Management
Maryland
$124M 2,654,729 +237,236 +10%
Janus Henderson Group
13
Janus Henderson Group
United Kingdom
$92.5M 1,978,172 +1,434,909 +264%
FLAM
14
First Light Asset Management
Minnesota
$79.1M 1,690,177 -297,595 -15%
PA
15
Perceptive Advisors
New York
$69.1M 1,476,203 +220,691 +18%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$65.6M 1,401,403 +48,731 +4%
AG
17
Artal Group
Luxembourg
$65.1M 1,390,477 +1,390,477 New
O
18
OrbiMed
New York
$64.8M 1,385,000 -282,360 -17%
CAM
19
Cormorant Asset Management
Massachusetts
$53.8M 1,150,000 – –
NHAS
20
Novo Holdings A/S
Denmark
$51.4M 1,098,600 -1,400 -0.1%
EAM
21
Eventide Asset Management
Massachusetts
$49.6M 1,059,633 – –
Lord, Abbett & Co
22
Lord, Abbett & Co
New Jersey
$45.2M 964,568 +187,280 +24%
Goldman Sachs
23
Goldman Sachs
New York
$40.4M 864,107 +213,934 +33%
SVCM
24
Saturn V Capital Management
Texas
$30.9M 660,143 -126,989 -16%
IC
25
Ikarian Capital
Texas
$30.1M 643,751 -36,619 -5%
1
2 3 4 5